ANO7 and cancer: In the comparison between carriers and non-carriers, only one intron was found to be significantly differently retained on the genome-wide level in both the benign and cancer condition; intron 3 in ANO7 (intron retention change, IRchange 0.295, q = 3.90 × 10−7and IRchange 0.323, q = 1.70 × 10−4, respectively).